HealthEx and 23andMe have announced a strategic partnership designed to connect comprehensive electronic medical records directly with consumer genomic profiles. The collaboration enables users to securely combine real-world clinical data—including laboratory results, diagnoses, and prescription histories—with genetic information to create more personalized health insights and disease risk models.
The initiative addresses a longstanding challenge in consumer genomics, where genetic insights have historically existed separately from clinical health records. While DNA analysis can indicate statistical predispositions to disease, medical records provide evidence of how health conditions manifest over time. The integration seeks to unify these previously isolated data sources into a single consumer-controlled framework.
The partnership is built on federal interoperability standards through the Trusted Exchange Framework and Common Agreement (TEFCA). HealthEx operates as a recognized Individual Access Services provider under TEFCA and uses Fast Healthcare Interoperability Resources (FHIR) standards to facilitate secure data exchange between health systems and the 23andMe platform.
Through a web-based consent process, consumers can verify their identities and authorize the transfer of structured clinical data directly into their 23andMe accounts without relying on external applications or manual document uploads. Users retain the ability to grant or revoke access to their information at any time.
Anne Wojcicki, CEO and Founder at 23andMe, emphasized that while genetics has always served as the foundation of their platform, traditional clinical data completes the story. Partnering with HealthEx delivers the secure, friction-free data architecture required to pull in this real-world context while keeping the individual in complete control of their information.
The combined dataset will serve as the foundation for 23andMe’s planned AI-driven “Health Summary” platform. According to the companies, the tool will analyze genomic information alongside longitudinal laboratory trends, pharmaceutical histories, and lifestyle data to generate personalized disease risk assessments and preventative care recommendations.
Priyanka Agarwal, M.D., MBA, co-founder and CEO of HealthEx, noted that adding real-time clinical milestones unlocks insights that genetics alone cannot surface, providing consumers with a connected picture of their overall health and the automated tools required to act on it.
The partnership also reflects broader industry movement toward interoperability infrastructure and AI-enabled healthcare applications. As healthcare organizations increasingly prioritize data mobility and collaborative AI development, the companies position the initiative as a model for integrating genomics, clinical records, and behavioral health information into consumer-centered healthcare platforms.
Click here for the original news story.
